CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleMarket cap is $1.59B, above the global median of $1.18B
- PositionReturn on equity is 21.5%, higher than 95% of its Specialty Chemicals peers (median 5.4%)
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.30%Above 5Y avg (2.66%)
Annual Rate
CNY 1.50Paid annual
Payout Ratio
65.7%Moderate
Payback Period
18.7 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.63BCNY1.59B · vs all stocks (USD)
Trailing P/E
12.18xvs Specialty Chemicals peers
Revenue (TTM)
3.79BCNY565.25M · vs all stocks (USD)
Profit Margin
20.62%vs Specialty Chemicals peers
Beta
-0.0390xvs all stocks
52-Week Change
-35.43%vs all stocks
Market Capitalization
10.63BCNY1.59B · vs all stocks (USD)
Enterprise Value
10.20BCNY1.52B · vs all stocks (USD)
Trailing P/E
12.18xvs Specialty Chemicals peers
Forward P/E
10.69xvs Specialty Chemicals peers
Price to Sales (TTM)
2.81xvs Specialty Chemicals peers
Price to Book (MRQ)
2.76xvs Specialty Chemicals peers
Enterprise to Revenue
2.69xvs Specialty Chemicals peers
Enterprise to EBITDA
12.48xvs Specialty Chemicals peers
Gross Margin
32.63%vs Specialty Chemicals peers
Profit Margin
20.62%vs Specialty Chemicals peers
Operating Margin
15.86%vs Specialty Chemicals peers
Return on Assets (TTM)
8.80%vs Specialty Chemicals peers
Return on Equity (TTM)
21.51%vs Specialty Chemicals peers
Revenue (TTM)
3.79BCNY565.25M · vs all stocks (USD)
Revenue per Share (TTM)
10.86CNYUpdated Sep 21, 2026Quarterly Revenue Growth
31.00%vs Specialty Chemicals peers
Gross Profit (TTM)
1.25BCNY187.12M · vs all stocks (USD)
EBITDA (TTM)
940.83MCNY140.39M · vs all stocks (USD)
Net Income (TTM)
781.04MCNY116.55M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
56.90%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
447.44MCNY66.77M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
152.84MCNY22.81M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.50CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
5.30%vs all stocks
5-Year Average Dividend Yield
2.66%vs all stocks
Payout Ratio
65.70%vs Specialty Chemicals peers
Minority Interest (Equity)
27.82MCNYFY2025 · Dec 31, 2025Revenue
3.51BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.29BCNYFY2025 · Dec 31, 2025Gross Profit
1.21BCNYFY2025 · Dec 31, 2025Operating Income
830.03MCNY123.86M · vs all stocks (USD)
Pre-tax Income
851.53MCNYFY2025 · Dec 31, 2025Income Tax Expense
109.90MCNYFY2025 · Dec 31, 2025Net Income
741.63MCNYFY2025 · Dec 31, 2025EBIT
863.32MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
940.83MCNYFY2025 · Dec 31, 2025Research & Development
160.60MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
85.71MCNYFY2025 · Dec 31, 2025Other Operating Expenses
21.39MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
11.80MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.92CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.92CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
382.92MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
382.92MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
741.63MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.24MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
659.82MCNYFY2025 · Dec 31, 2025Free Cash Flow
342.03MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
834.21MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
741.63MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.13MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-138.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
37.34MCNYFY2025 · Dec 31, 2025Capital Expenditures
-317.80MCNYFY2025 · Dec 31, 2025Purchase of Investments
-117.08MCNYFY2025 · Dec 31, 2025Sale of Investments
5.78MCNYFY2025 · Dec 31, 2025Other Investing Activity
10.63MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-418.47MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
607.88MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-286.58MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-358.92MCNYFY2025 · Dec 31, 2025Other Financing Charges
69.47MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
31.85MCNYFY2025 · Dec 31, 2025Shares Outstanding
383.04MSharesUpdated Sep 21, 2026Float Shares
181.47MSharesUpdated Sep 21, 2026% Held by Insiders
50.76%vs all stocks
% Held by Institutions
16.30%vs all stocks
Total Cash (MRQ)
1.33BCNY198.84M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.53CNYUpdated Sep 21, 2026Total Debt (MRQ)
1.03BCNY153.05M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2682xvs Specialty Chemicals peers
Current Ratio (MRQ)
1.90xvs Specialty Chemicals peers
Book Value per Share (MRQ)
10.05CNYUpdated Sep 21, 2026Total Assets
5.10BCNY760.47M · vs all stocks (USD)
Total Current Assets
3.01BCNYFY2025 · Dec 31, 2025Total Liabilities
1.25BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.09BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
151.63MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.10BCNYFY2025 · Dec 31, 2025Cash
834.15MCNYFY2025 · Dec 31, 2025Cash Equivalents
7.05MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
841.19MCNYFY2025 · Dec 31, 2025Other Short-term Investments
906.21MCNYFY2025 · Dec 31, 2025Accounts Receivable
485.35MCNYFY2025 · Dec 31, 2025Inventory
535.78MCNYFY2025 · Dec 31, 2025Accounts Payable
371.67MCNYFY2025 · Dec 31, 2025Short-term Debt
562.58MCNYFY2025 · Dec 31, 2025Other Current Liabilities
490.61KCNYFY2025 · Dec 31, 2025Long-term Debt
138.57MCNYFY2025 · Dec 31, 2025Common Stock (Book)
295.94MCNYFY2025 · Dec 31, 2025Retained Earnings
1.80BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.85BCNY574.36M · vs all stocks (USD)
Treasury Stock
228.20MCNYFY2025 · Dec 31, 202552-Week Low
25.02CNYUpdated Sep 21, 202652-Week High
51.00CNYUpdated Sep 21, 202652-Week Change
-35.43%vs all stocks
Beta
-0.0390xvs all stocks
50-Day MA
28.28CNYUpdated Sep 21, 2026200-Day MA
36.24CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.88MSharesUpdated Sep 21, 2026Avg 30-Day Volume
6.25MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
2.28CNYUpdated Sep 21, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 21.5%, higher than 95% of its Specialty Chemicals peers (median 5.4%)Significant
Return on equity: 0.22Industry median: 0.05Industry P95: 0.17Peers compared: 132
P/E ratio is 12.18×, lower than 95% of its Specialty Chemicals peers (median 38.15×)Notable
P/E ratio: 12.18Industry median: 38.15Industry P5: 12.19Peers compared: 132
Financial Health
Altman Z-Score 7.31: safe zoneNotable
Altman Z-Score: 7.31
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is $1.59B, above the global median of $1.18BNotable
Market cap (USD): 1,586,694,103.535Global Median: 1,180,223,658.953
Revenue is $565.25M, above the global median of $548.88MNotable
Revenue (USD): 565,254,184.274Global Median: 548,883,780.48
Levered free cash flow is $22.81M, above the global median of $18.73MNotable
Levered free cash flow (USD): 22,806,622.449Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Suzhou Slac Precision Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Dcm Shriram Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hangzhou Kelin Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Ganga Papers India Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Yantai Zhenghai Magnetic Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Longhua Technology Group Luoyang Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Landis+Gyr Group AG
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Weifu High Technology Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dongjin Semichem Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Guangzhou Zhiguang Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Suzhou TFC Optical Communication Co., Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedOperating Income Growing With Multi-Year Revenue Growth
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA Elevated
Shanghai Bochuan Electronic Co., Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedOperating Income Growing With Multi-Year Revenue Growth
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.